Dr Gevorg Tamamyan is Nominated as a Candidate for WHO Director-General Position
Immuno 2026 Day 3 Highlights: Cancer Vaccines, Local Immunotherapy and the Patient Perspective
KEYNOTE-671: Perioperative Pembrolizumab Redefines Curative-Intent Therapy in Resectable NSCLC
Highlights from World Cancer Congress 2026
Gustavo Fonseca at COGC 2026: Making Community Clinical Trials Truly Work
IMpassion050 Final Results: Atezolizumab Does Not Improve Long-Term Outcomes in High-Risk HER2-Positive Early Breast Cancer
Daiichi Sankyo and Merck Withdraw Ifinatamab Deruxtecan BLA for Previously Treated Extensive-Stage SCLC
Victor Moreno: Bringing Lirafugratinib From a First-In-Human Trial to an FDA-Approved Treatment
Organized by the American Society of Clinical Oncology (ASCO), the 2026 Oncology Training Program Leadership Retreat will take place on 12–13 November 2026 at ASCO Headquarters in Alexandria, Virginia. The in-person retreat is designed for hematology and oncology training programme leaders, including programme directors, associate programme directors, key clinical faculty, and eligible programme coordinators. The […]
The 2027 ASCO GI Cancers Symposium, organized by the American Society of Clinical Oncology (ASCO), will take place on 21–23 January 2027 at Moscone West in San Francisco, California. Held […]
